IL165731A0 - Novel hexahydro-pyridazine-3-carboclic acid hydrazide or hydrazone derivatives, combinatorial libra ries containing same, use thereof as medicines, p harmaceutical compositions containing same and methods for preparing same - Google Patents

Novel hexahydro-pyridazine-3-carboclic acid hydrazide or hydrazone derivatives, combinatorial libra ries containing same, use thereof as medicines, p harmaceutical compositions containing same and methods for preparing same

Info

Publication number
IL165731A0
IL165731A0 IL16573104A IL16573104A IL165731A0 IL 165731 A0 IL165731 A0 IL 165731A0 IL 16573104 A IL16573104 A IL 16573104A IL 16573104 A IL16573104 A IL 16573104A IL 165731 A0 IL165731 A0 IL 165731A0
Authority
IL
Israel
Prior art keywords
same
containing same
carboclic
pyridazine
combinatorial
Prior art date
Application number
IL16573104A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL165731A0 publication Critical patent/IL165731A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/11—Compounds covalently bound to a solid support
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL16573104A 2002-06-14 2004-12-12 Novel hexahydro-pyridazine-3-carboclic acid hydrazide or hydrazone derivatives, combinatorial libra ries containing same, use thereof as medicines, p harmaceutical compositions containing same and methods for preparing same IL165731A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0207346A FR2840898B1 (fr) 2002-06-14 2002-06-14 Derives hydrazide ou hydrazone de l'acide hexahydropyridazine-3-carboxylique, chimiotheques et compositions pharmaceutiques les contenant, utilisation comme medicaments, et procede de preparation
PCT/FR2003/001770 WO2003106431A2 (fr) 2002-06-14 2003-06-12 Nouveaux derives hydrazide ou hydrazone de l'acide hexahydro-pyridazine-3-carboxylique, chimiotheques les contenant, leur utilisation comme medicaments, compositions pharmaceutiques les contenant et leurs procedes de preparation

Publications (1)

Publication Number Publication Date
IL165731A0 true IL165731A0 (en) 2006-01-15

Family

ID=29595243

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16573104A IL165731A0 (en) 2002-06-14 2004-12-12 Novel hexahydro-pyridazine-3-carboclic acid hydrazide or hydrazone derivatives, combinatorial libra ries containing same, use thereof as medicines, p harmaceutical compositions containing same and methods for preparing same

Country Status (10)

Country Link
US (1) US7279480B2 (de)
EP (1) EP1515953A2 (de)
JP (1) JP2005530823A (de)
AU (1) AU2003260582A1 (de)
BR (1) BR0312127A (de)
CA (1) CA2489447A1 (de)
FR (1) FR2840898B1 (de)
IL (1) IL165731A0 (de)
MX (1) MXPA04010747A (de)
WO (1) WO2003106431A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7725386B2 (en) * 2004-03-15 2010-05-25 Arthur J Prieston Method for offering representation and warranty insurance for mortgage loans
WO2008054633A1 (en) * 2006-10-31 2008-05-08 Janssen Pharmaceutica N.V. Hydrazone derivatives as kinase inhibitors

Also Published As

Publication number Publication date
US20050215553A1 (en) 2005-09-29
CA2489447A1 (fr) 2003-12-24
FR2840898A1 (fr) 2003-12-19
US7279480B2 (en) 2007-10-09
MXPA04010747A (es) 2005-03-07
WO2003106431A2 (fr) 2003-12-24
FR2840898B1 (fr) 2004-08-27
BR0312127A (pt) 2005-03-29
JP2005530823A (ja) 2005-10-13
WO2003106431A3 (fr) 2004-04-08
AU2003260582A1 (en) 2003-12-31
EP1515953A2 (de) 2005-03-23

Similar Documents

Publication Publication Date Title
IL190218A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
PL372998A1 (en) Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
IL179757A (en) Fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, process for preparing such medicaments and the use thereof
IL163831A (en) Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
SI1572708T1 (sl) Novi heterociklicni fluoroglikozidni derivati, zdravila, ki vsebujejo te spojine, in njihova uporaba
NO20050828L (no) lndol-3-svovelderivater
DK1523488T3 (da) Nye thiophenglycosidderivater, fremgangsmåder til deres fremstilling, lægemidler indeholdende disse forbindelser og deres anvendelse
SE0200920D0 (sv) Novel compounds
IL178297A0 (en) Hydrazide derivatives and pharmaceutical compositions containing the same
WO2004039753A3 (en) Phenyl compounds
AU2003239302A1 (en) Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
HUP0303128A3 (en) Novel succinate salt of o-desmethyl-venlafaxine, process for preparation thereof, its use and pharmaceutical composition containing it
IL169500A0 (en) Pyrrolopyridazine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
WO2004093800A3 (en) Thyronamine derivatives and analogs and methods of use thereof
HUP0103063A3 (en) Novel 2h-pyridazin-3-one derivatives, process for their preparation, their use and pharmaceutical compositions containing them
IL149370A0 (en) 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
HUP0200438A3 (en) Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
DK1560826T3 (da) Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
NO20063062L (no) Imidazolderivater, fremgangsmate for fremstilling og anvendelse av disse
ZA200500203B (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
AU2003273473A1 (en) Novel substituted pyrazolo(1,5 less thanigreater thanaless than/igreater than)-1,3,5-triazine derivatives and their analogues, pharmaceutical compositions containing same, use thereof as medicine and methods for preparing same
IL163643A0 (en) Oxazolidinone derivatives, processes for their forpreparation, and pharmaceutical compositions containing them
IL162844A0 (en) Use of an expression vector for preparing pharmaceutical compositions
IL165731A0 (en) Novel hexahydro-pyridazine-3-carboclic acid hydrazide or hydrazone derivatives, combinatorial libra ries containing same, use thereof as medicines, p harmaceutical compositions containing same and methods for preparing same